Methoxamine rectal - Norgine

Drug Profile

Methoxamine rectal - Norgine

Alternative Names: 1R, 2S-methoxamine hydrochloride; 1R,2S-methoxamine rectal - Norgine; L-Erythro-methoxamine rectal - Norgine; NRL-001

Latest Information Update: 20 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Norgine
  • Class Antiarrhythmics; Antihypotensives; Phenethylamines; Propanolamines; Small molecules; Vasoconstrictors
  • Mechanism of Action Alpha 1 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Faecal incontinence

Most Recent Events

  • 17 Sep 2015 Phase-II development for Faecal incontinence is ongoing in France, United Kingdom, Italy, Germany, Czech Republic, Hungary, Poland, Sweden and Spain (Rectal, suppository)
  • 25 Jul 2013 Phase-II clinical trials in Faecal Incontinence in Germany, Hungary, Italy, Poland, Czech Republic, Sweden & Spain (Rectal)
  • 29 Feb 2012 Phase-II clinical trials in Faecal Incontinence in France (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top